Premium
Non‐steroidal anti‐inflammatory drugs
Author(s) -
Johnson Anthony G,
Quinn David I,
Day Richard O
Publication year - 1995
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1995.tb127972.x
Subject(s) - medicine , piroxicam , phenylbutazone , drug , adverse effect , nonsteroidal , pharmacology , anti inflammatory , intensive care medicine , alternative medicine , pathology
The elderly are at higher risk of adverse reactions from non‐steroidal anti‐inflammatory drugs (NSAIDs), including those due to drug interactions, than younger people. Before prescribing oral NSAIDs in the elderly, the clinician should consider other forms of therapy and topical NSAIDs. When an oral NSAID is used, the dose should be minimised and the need for treatment reviewed periodically to reduce duration of therapy. NSAIDs with a high risk of toxicity (such as phenylbutazone, salicylates, piroxicam and indomethacin) should be avoided in the elderly.